Ashish Jha, White House COVID-19 response coordinator: “We are, I believe, we are at an inflection point. One hand, we know that BA.2, the sub variant of Omicron, has become dominant. Cases are rising across the country, but hospitalizations are at the lowest level of the pandemic. Right? And deaths are continuing to fall. We’re down to about 300 deaths day. Still too many, still too high, but doing so much better than we have throughout much of this pandemic.”
Reporter: “The president is getting ready to ramp up his travel schedule. The vice president just got it. She’s twice boosted. Should Americans be prepared for a time when President Biden gets this? Is it just a matter of time that the president could get COVID?”
Ashish Jha, White House COVID-19 response coordinator: “I wouldn’t say it’s just a matter of time, but of course, it is possible that the president, like any other American, could get COVID. The bottom line is he is vaccinated and boosted. He is very well-protected. He’s got very good protocols around him to protect him from getting infected. But there is no 100% anything. And I think the key focus has got to be we’ve got to continue protecting the president. That’s what the protocols around him are designed to do.”
“Paxlovid became authorized by the FDA in late December. But now we’re opening up a federal federal pharmacy channel and what that means is pharmacies can order directly from the federal government. Currently, there are about 20,000 sites in the United States that carry Paxlovid. We expect with this change that we will very quickly get to 30,000 and within the next couple of weeks I expect us to get to about 40,000 sites. Paxlovid will be widely available everywhere in America.”
“And what we need to do is to help American physicians and nurse practitioners and others who can prescribe, understand that we now have plenty available. And anybody who is eligible, anybody who’s high risk should be getting Paxlovid, obviously based … as long as they meet the clinical criteria.”